Clinical Trial Update: Evaluation of Antibody Persistence & Immune Memory in Subjects Vaccinated During Adolescence With Twinrix™ [Phase 4]

View source ↗

Summary

Phase 4 trial updating antibody persistence and immune memory after adolescence vaccination with Twinrix, focusing on Hepatitis A and B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis A
• Hepatitis B

Drugs mentioned

• Twinrix (Hepatitis A and B vaccine, combined)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B, Hepatitis A | Phase 4 | Status: COMPLETED | Results posted: 2010-07-05